ReStore Liposome

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameReStore Liposome
Drug Alias NameTySIPonate/Nox4-smi antibody-conjugated liposome (Restore therapeutics/University of Arizona)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate
Mechanisms of ActionNADPH oxidase 4 inhibitors
TargetsNADPH oxidase 4
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultLung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRestore Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRestore Therapeutics LLCThe University Of Arizona
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, AdultLung Injury

Other Information

ATC CodeN/A
Related LinksN/A